Introduction: Metastasis involves the accumulation of genetic and epigenetic alterations leading to activation of prometastatic genes and inactivation of antimetastatic genes. Among epigenetic alterations, DNA hypermethylation and histone hypoacetylation are the focus of intense translational research because their pharmacological inhibition has been shown to produce antineoplastic activity in a variety of experimental models.
Aims: This study aimed to evaluate the antimetastatic effect of the DNA-methylation inhibitor, hydralazine, and the histone deacetylase inhibitor, valproic acid.
Methods: NIH 3T3- murine cells were treated with hydralazine and valproic acid to evaluate their effects upon cell proliferation, cell motility, chemotaxis, gelatinase activity, and gene expression. Lung metastases were developed by intravenous injection of NIH 3T3- cells in BALB/c nu/nu mice and then treated with the drug combination.
Results: Treatment induced a growth-inhibitory effect on NIH 3T3- cells, showed a trend toward increased gelatinase activity of MMP2 and MMP9, and inhibited chemotaxis and cell motility. The combination led to a strong antimetastatic effect in lungs of nude mice.
Conclusion: Hydralazine and valproic acid, two repositioned drugs as epigenetic agents, exhibit antimetastatic effects in vitro and in vivo and hold potential for cancer treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290866 | PMC |
| http://dx.doi.org/10.2147/OTT.S187306 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Common teratogenic medication exposures-a population-based study of pregnancies in the United States.
Am J Obstet Gynecol MFM
January 2024
Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL (Ms Wang and Drs Smolinski, Thai, Sarayani, Ewig, and Winterstein); Department of Epidemiology, College of Medicine and College of Public Health and Health Professions, University of Florida, Gainesville, FL (Dr Winterstein); Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL (Dr Winterstein). Electronic address:
Background: Risk mitigation for most teratogenic medications relies on risk communication via drug label, and prenatal exposures remain common. Information on the types of and risk factors for prenatal exposures to medications with teratogenic risk can guide strategies to reduce exposure.
Objective: This study aimed to identify medications with known or potential teratogenic risk commonly used during pregnancy among privately insured persons.
Efficacy and Safety of Valproic Acid in Myelodysplastic Syndrome and Acute Myeloid Leukemia; a Narrative Review.
Drug Res (Stuttg)
September 2023
Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Article Synopsis
- New therapies for Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are being explored, especially for older patients who can't tolerate intensive chemotherapy.
- MDS is a group of disorders that affect blood cell production and can lead to AML, and treatments often come with high rates of side effects.
- Research indicates that valproic acid may be a safe and effective option when combined with other medications, but more clinical trials are needed to determine the best treatment strategies.
Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine.
Stem Cell Res Ther
March 2023
Departamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, 64720, Monterrey, Nuevo León, Mexico.
Background: The generation of induced pluripotent stem cells has opened the field of study for stem cell research, disease modeling and drug development. However, the epigenetic signatures present in somatic cells make cell reprogramming still an inefficient process. This epigenetic memory constitutes an obstacle in cellular reprogramming.
View Article and Find Full Text PDFRegenerative Drug Discovery Using Ear Pinna Punch Wound Model in Mice.
Pharmaceuticals (Basel)
May 2022
Laboratory for Regenerative Biotechnology, Gdańsk University of Technology, 80-233 Gdańsk, Poland.
The ear pinna is a complex tissue consisting of the dermis, cartilage, muscles, vessels, and nerves. Ear pinna healing is a model of regeneration in mammals. In some mammals, including rabbits, punch wounds in the ear pinna close spontaneously; in common-use laboratory mice, they remain for life.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!